Xtant Medical Holdings, Inc. (XTNT) stock
XTNTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 9/3080% below fair value
$0.21+0.00 (+0.29%)
Close on Nov 18, 2026Market cap $28.87MP/E –Yield –
Xtant Medical free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Xtant Medical's free cash flow for the twelve months ending Jun 30, 2026 was -$696.00K. For fiscal 2025 it was $10.16M. The highest annual figure on record is $10.16M in fiscal 2025.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.16M | – |
| FY2024 | Dec 31, 2024 | -$16.01M | – |
| FY2023 | Dec 31, 2023 | -$10.97M | – |
| FY2022 | Dec 31, 2022 | -$7.11M | – |
| FY2021 | Dec 31, 2021 | -$1.68M | – |
| FY2020 | Dec 31, 2020 | -$2.28M | – |
| FY2019 | Dec 31, 2019 | -$1.29M | -319.7% |
| FY2018 | Dec 31, 2018 | $588.00K | – |
| FY2017 | Dec 31, 2017 | -$2.18M | – |
| FY2016 | Dec 31, 2016 | -$20.24M | – |
| FY2015 | Dec 31, 2015 | -$11.36M | – |
| FY2014 | Dec 31, 2014 | -$7.62M | – |
| FY2013 | Dec 31, 2013 | -$5.52M | – |
| FY2012 | Dec 31, 2012 | -$12.62M | – |
| FY2011 | Dec 31, 2011 | -$8.32M | – |
| FY2010 | Dec 31, 2010 | -$9.16M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$7.56M | -930.2% |
| Q1 FY2026 | Mar 31, 2026 | -$2.31M | -2752.9% |
| Q4 FY2025 | Dec 31, 2025 | $4.99M | – |
| Q3 FY2025 | Sep 30, 2025 | $4.18M | – |
| Q2 FY2025 | Jun 30, 2025 | $910.00K | – |
| Q1 FY2025 | Mar 31, 2025 | $87.00K | – |
| Q4 FY2024 | Dec 31, 2024 | -$7.00K | – |
| Q3 FY2024 | Sep 30, 2024 | -$3.82M | – |
| Q2 FY2024 | Jun 30, 2024 | -$5.65M | – |
| Q1 FY2024 | Mar 31, 2024 | -$6.53M | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.28M | – |
| Q3 FY2023 | Sep 30, 2023 | -$4.06M | – |
| Q2 FY2023 | Jun 30, 2023 | -$2.94M | – |
| Q1 FY2023 | Mar 31, 2023 | -$2.70M | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.73M | – |
| Q3 FY2022 | Sep 30, 2022 | -$2.58M | – |
| Q2 FY2022 | Jun 30, 2022 | -$311.00K | -118.2% |
| Q1 FY2022 | Mar 31, 2022 | -$1.49M | – |
| Q4 FY2021 | Dec 31, 2021 | -$203.00K | -173.0% |
| Q3 FY2021 | Sep 30, 2021 | -$1.34M | – |
| Q2 FY2021 | Jun 30, 2021 | $1.71M | – |
| Q1 FY2021 | Mar 31, 2021 | -$1.85M | – |
| Q4 FY2020 | Dec 31, 2020 | $278.00K | – |
| Q3 FY2020 | Sep 30, 2020 | -$305.00K | – |
| Q2 FY2020 | Jun 30, 2020 | -$202.00K | -151.8% |
| Q1 FY2020 | Mar 31, 2020 | -$2.05M | -679.9% |
| Q4 FY2019 | Dec 31, 2019 | -$547.00K | -132.7% |
| Q3 FY2019 | Sep 30, 2019 | -$1.49M | – |
| Q2 FY2019 | Jun 30, 2019 | $390.00K | – |
| Q1 FY2019 | Mar 31, 2019 | $353.00K | +239.4% |
| Q4 FY2018 | Dec 31, 2018 | $1.68M | +263.3% |
| Q3 FY2018 | Sep 30, 2018 | -$1.14M | – |
| Q2 FY2018 | Jun 30, 2018 | -$48.00K | – |
| Q1 FY2018 | Mar 31, 2018 | $104.00K | -18.1% |
| Q4 FY2017 | Dec 31, 2017 | $461.00K | – |
| Q3 FY2017 | Sep 30, 2017 | -$821.00K | – |
| Q2 FY2017 | Jun 30, 2017 | -$1.95M | – |
| Q1 FY2017 | Mar 31, 2017 | $127.00K | – |
| Q4 FY2016 | Dec 31, 2016 | -$3.48M | – |
| Q3 FY2016 | Sep 30, 2016 | -$4.64M | – |
See a number that looks wrong?